This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nash, K.
Right arrow Articles by Muzyczka, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nash, K.
Right arrow Articles by Muzyczka, N.

 Previous Article  |  Next Article 

Journal of Virology, June 2007, p. 5777-5787, Vol. 81, No. 11
0022-538X/07/$08.00+0     doi:10.1128/JVI.02651-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Purification of Host Cell Enzymes Involved in Adeno-Associated Virus DNA Replication{triangledown}

Kevin Nash, Weijun Chen, William F. McDonald, Xiaohuai Zhou, and Nicholas Muzyczka*

University of Florida, Department of Molecular Genetics and Microbiology and Powell Gene Therapy Center, 1376 Mowry Rd., Gainesville, Florida 32610

Received 30 November 2006/ Accepted 6 March 2007


arrow
ABSTRACT
 
Adeno-associated virus (AAV) replicates its DNA by a modified rolling-circle mechanism that exclusively uses leading strand displacement synthesis. To identify the enzymes directly involved in AAV DNA replication, we fractionated adenovirus-infected crude extracts and tested them in an in vitro replication system that required the presence of the AAV-encoded Rep protein and the AAV origins of DNA replication, thus faithfully reproducing in vivo viral DNA replication. Fractions that contained replication factor C (RFC) and proliferating cell nuclear antigen (PCNA) were found to be essential for reconstituting AAV DNA replication. These could be replaced by purified PCNA and RFC to retain full activity. We also found that fractions containing polymerase {delta}, but not polymerase {varepsilon} or {alpha}, were capable of replicating AAV DNA in vitro. This was confirmed when highly purified polymerase {delta} complex purified from baculovirus expression clones was used. Curiously, as the components of the DNA replication system were purified, neither the cellular single-stranded DNA binding protein (RPA) nor the adenovirus-encoded DNA binding protein was found to be essential for DNA replication; both only modestly stimulated DNA synthesis on an AAV template. Also, in addition to polymerase {delta}, RFC, and PCNA, an as yet unidentified factor(s) is required for AAV DNA replication, which appeared to be enriched in adenovirus-infected cells. Finally, the absence of any apparent cellular DNA helicase requirement led us to develop an artificial AAV replication system in which polymerase {delta}, RFC, and PCNA were replaced with T4 DNA polymerase and gp32 protein. This system was capable of supporting AAV DNA replication, demonstrating that under some conditions the Rep helicase activity can function to unwind duplex DNA during strand displacement synthesis.


arrow
INTRODUCTION
 
Adeno-associated virus (AAV), like all parvoviruses, replicates by a strand displacement method using a hairpined terminal repeat (TR) as a primer. The hairpin primer is used to synthesize a duplex DNA molecule that is covalently closed at one or both ends (Fig. 1). In a process called terminal resolution the TR is cleaved at a unique site on one strand (the terminal resolution site [trs]) and the hairpined TR is repaired to make an open-ended duplex intermediate. The repaired TR is denatured and reannealed to form a double-hairpin intermediate that initiates strand displacement synthesis (Fig. 1, reinitiation), and strand displacement from this intermediate then generates a single-stranded genome that is packaged. The virally encoded Rep78 and Rep68 proteins have been shown to have the site-specific DNA helicase and endonuclease activities required to carry out both terminal resolution and reinitiation in vitro (17, 19, 35). However, it is not yet clear what other enzymes are necessary for AAV DNA synthesis.


Figure 1
View larger version (11K):
[in this window]
[in a new window]

  		FIG. 1. Mechanism of AAV DNA replication. The scheme illustrates the key steps during AAV DNA replication with NE DNA substrate (NE). The alternative linear dsDNA substrate generated from the PvuII digestion of psub201 is also shown (PvuII). Horizontal arrows indicate 3' ends, black dots represent the 5' ends, and trs indicates the terminal resolution sites. Note that the monomer duplex (md) intermediate exists in two forms, with and without a covalently closed, hairpinned end.

AAV requires a helper virus for efficient DNA replication and viral propagation (26). AAV infection in the absence of a helper virus produces little AAV gene expression and virtually no DNA amplification (26). It is believed that only complementary (second-strand) synthesis occurs in the absence of helper virus, although this is often an inefficient process, which takes weeks or months to complete (36). In contrast, in the presence of helper, AAV replication and gene expression initiate within 8 h of cell infection and rapidly generate 500,000 to 1,000,000 viral particles and severalfold more genomes that are not packaged (5, 27). This represents at least a 100-fold increase in AAV DNA replication over a variety of methods that have been shown to induce AAV DNA replication in the absence of helper virus, including UV, heat shock, and topoisomerase inhibitors (51, 52).

It is believed that adenovirus (Ad) is the normal helper in the natural environment because AAV has been isolated most often as a contaminant of clinical Ad isolates (1, 2, 32). Studies of Ad mutants suggest that Ad genes are primarily responsible for insuring AAV gene expression and perhaps for inducing and maintaining cells in S phase (26). The requirement for S phase would be consistent with the fact that the related autonomous parvoviruses typically replicate only after cells enter S phase. With one exception, the Ad DNA binding protein (DBP) gene, none of the Ad genes required by AAV are directly involved in DNA replication. The Ad DNA polymerase and Ad terminal protein are dispensable for AAV DNA replication (20, 21, 27, 38). This suggests that AAV primarily uses cellular replication enzymes when Ad is the helper.

The requirement for Ad DBP in AAV DNA replication has been controversial (6, 20, 21, 27, 38, 46). Mutations in the Ad DBP gene, including deletion of the gene, have a modest effect on DNA replication, lowering replication three- to fourfold in cells infected with AAV and the Ad DBP deletion mutant (6). Since Ad DBP seems to be required for efficient Rep gene transcription (7, 20) and since Rep protein levels are reduced when an Ad DBP deletion mutant is used as a helper (6), it is possible that the only effect of Ad DBP is an indirect effect on gene expression of both Rep and the AAV capsid genes. Several groups, however, have argued that the single-stranded DNA (ssDNA) binding protein may be the critical protein that allows AAV to replicate when helper virus is present (37, 46). First, Ad DBP, cellular replication protein A (RPA), and the herpesvirus UL29 protein, all of which are ssDNA binding proteins, are found to colocalize in infected nuclei with the AAV Rep protein and AAV DNA (14-16, 37, 49). Second, Rep protein has been shown to interact directly with RPA, Ad DBP, and UL29 (15, 37), and this interaction increases AAV DNA replication in vitro about fivefold by increasing processivity (45, 46) and by improving the site-specific endonuclease activity at the trs (37).

Studies of AAV DNA replication in herpesvirus-infected cells have suggested that two sets of proteins are necessary for AAV helper function, the herpesvirus helicase primase complex, which consists of the UL5, UL8, and UL52 proteins, and the herpesvirus ssDNA binding protein, UL29. Mutations in either complex produce profound effects on AAV replication in cell culture (48). Presumably, a cellular DNA polymerase is used in the case of herpesvirus coinfection as it is in the case of Ad. However, mutations in the herpesvirus DNA polymerase have also been shown to reduce AAV DNA synthesis by approximately 3 logs in cell culture (48). More recently, studies of helicase primase mutants have suggested that this complex may function to position AAV DNA at replication centers within the nucleus or that its helicase activity may stimulate AAV DNA synthesis in cell culture or both (34, 37). In addition, in vitro studies have shown that robust AAV DNA replication can be achieved with just the AAV Rep protein, the herpesvirus DNA polymerase complex (UL30/42), and UL29 (47).

Finally, AAV can also replicate its DNA and propagate efficiently in insect cells that have been infected with baculovirus vectors expressing the essential AAV rep and cap genes (23, 43, 44). Such cells can generate viral titers that are equal to those seen in human cells infected with wild-type AAV and either Ad or herpesvirus. This suggests that baculovirus-infected insect cells are a fully permissive environment for AAV DNA replication, but as yet nothing is known about the cellular or baculovirus factors that are essential.

Two groups have developed in vitro AAV DNA replication assays that faithfully recapitulate several aspects of AAV DNA synthesis in vivo (29, 45). These assays use AAV linear DNA that contains either open or covalently closed TRs at both ends (Fig. 1) and depend on the presence of both the AAV TR and Rep78 or Rep68 for efficient DNA synthesis. The assays appear, therefore, to be AAV specific. Both groups have also observed that Ad-infected-cell crude extracts are much more efficient (20- to 50-fold) in synthesizing full-length AAV DNA than uninfected extracts, and Ni et al. (29) have shown that all of the intermediates seen in vivo during AAV DNA replication are recapitulated in vitro. Ward et al. (46) supplemented crude uninfected extracts with purified Ad DBP and demonstrated a four- to fivefold stimulation of AAV replication activity. Ni et al. (28) used antibody inhibition of crude uninfected extracts and reconstitution assays using partially purified uninfected extracts to determine what activities might be necessary for AAV DNA replication. They concluded that RPA, PCNA, replication factor C (RFC), and an aphidocolin-sensitive polymerase could partially reconstitute AAV DNA synthesis in vitro.

In this report, we fractionate Ad-infected-cell extracts and use the in vitro replication assay to determine what cellular or Ad-encoded activities are necessary for reconstituting AAV DNA replication. We find that, in addition to RFC and PCNA, AAV DNA replication requires polymerase {delta} (Pol {delta}), but not Pol {varepsilon} or Pol {alpha}. Furthermore, as the system is purified, RPA and Ad DBP are no longer essential. We also present evidence that AAV Rep protein is capable of carrying out the strand displacement reaction ahead of the replication fork. Finally, we demonstrate that there are as yet unidentified cellular factors necessary for AAV DNA replication, which appear to be enriched in Ad-infected cells.


arrow
MATERIALS AND METHODS
 
Reagents. ECL Western blotting detection reagents were purchased from Amersham. [{alpha}-32P]dATP (3,000 Ci/mmol) and [{alpha}-3H]TTP were purchased from PerkinElmer. Phosphocellulose (P-Cell; P11) was acquired from Whatman. Bio-Gel HTP was purchased from Bio-Rad. Mono S, phenyl-Sepharose, DEAE-Sepharose, protein A- and protein G-Sepharose, CNBr-activated Sepharose, Q-Sepharose, poly(dA), and oligo(dT) were purchased from Amersham. Ni-nitrilotriacetic acid (NTA) agarose was purchased from QIAGEN. Nucleotides and salmon type III DNA were obtained from Sigma. HindIII, DpnI, and {lambda} DNA were purchased from New England Biolabs.

Antibodies. Mouse monoclonal PCNA antibody (PC10) was purchased from Santa Cruz Biotechnology. RPA antibody was purchased from either Neomarkers or Oncogene. Pol {delta} antibodies were purchased from Transduction Laboratories. Pol {alpha} antibody was purified from ATCC hybridoma SJK-237-71 with a protein G-Sepharose column. Pol {varepsilon} antibody was obtained from an ascitic preparation of ATCC hybridoma 3C5.1 and purified using a protein A-Sepharose column. Bruce Stillman (Cold Spring Harbor Laboratories) kindly provided RFC antibodies (to the 140-kDa subunit). Ad DBP antibody was provided by Arnold Levine (Princeton University).

Preparation of 293 cell extracts. Suspension cultures of human 293 cells were grown at 37°C in Jokliks modified essential medium supplemented with 10% bovine calf serum. Ad type 5 stocks were prepared as previously described and assayed on monolayers of 293 cells to determine titers (18). S100 extracts (also called crude extracts) were essentially prepared as described by Ni et al. (29). Briefly, 8 liters of 293 cells (5 x 105/ml) was infected with Ad (multiplicity of infection [MOI] of 5) and cultured for 40 h at 37°C. The infected cells were harvested at 1,000 x g for 10 min and then subjected to hypotonic lysis (20 mM HEPES, pH 7.5, 5 mM KCl, 1.5 mM MgCl2, 1.0 mM dithiothreitol [DTT]) and Dounce homogenization. NaCl was added to 0.2 M final concentration, and the lysed cells were incubated on ice for 15 min. Extracts were centrifuged 100,000 x g for 1 h at 4°C. The supernatants were frozen in liquid nitrogen and stored at –80°C. Uninfected-cell extracts were prepared in the same manner except the cells were grown to a density of 1 x 106 cells/ml. All subsequent fractionation was performed at 4°C.

P-Cell chromatography of crude extract. P-Cell fractionation of the S100 extract was performed as described by Tsurimoto and Stillman (40, 41) (Fig. 2). A column was equilibrated with buffer A (25 mM Tris-HCl, pH 7.5, 1 mM EDTA, 10% glycerol, 0.01% NP-40, 1 mM DTT, 0.1 mM phenylmethylsulfonyl fluoride, 0.5 µg/ml leupeptin, 0.7 µg/ml pepstatin A) containing 0.2 M NaCl before loading the extract. The flowthrough fraction was designated fraction I. The column was washed with at least 5 volumes of the equilibration buffer before the elution of the bound proteins with a four-step gradient. Elution was performed using a step gradient with NaCl concentrations of 0.33 M (fraction IIA), 0.4 M (fraction IIB), 0.66 M (fraction IIC), and 1.0 M (fraction IID). The peak fractions were pooled and dialyzed against buffer A containing 25 mM NaCl and 20% sucrose.


Figure 2
View larger version (24K):
[in this window]
[in a new window]

  		FIG. 2. Fractionation scheme of cellular replication proteins. The P-Cell and Q-Sepharose chromatography steps used to isolate DNA replication factors from Ad-infected-cell extracts (S100) are outlined. The protein fractions generated following each chromatography step (P-Cell I, IIA, IIC, and IID; Q-Sepharose, IA, IB, IC, and ID) are indicated. The NaCl concentrations used to elute each fraction are also noted. In some instances the 0.4 M NaCl elution was not performed and the elution with 0.66 M NaCl was termed fraction IIC' (not shown). Additional chromatography steps used for the purification of Pol {delta}, Pol {varepsilon}, and RFC are also shown.

Q-Sepharose chromatography of fraction I. Fraction I was further purified on a Q-Sepharose column (Fig. 2) using a modified method of Prelich et al. (30). The column was preequilibrated with buffer A containing 0.1 M NaCl. The sample was also adjusted to 0.1 M NaCl. The flowthrough (fraction IA) was collected and the column washed with the equilibration buffer. The bound proteins were eluted with a step gradient of 0.25 M (IB), 0.45 M (IC), and 1.0 M (ID) NaCl. The peak fractions were pooled and dialyzed as described above.

Replication proteins. Baculovirus-expressed AAV Rep78 was purified as previously described (28). Baculovirus clones of RPA subunits were kindly provided by Jesper Christensen (8). The baculoviruses were used to infect Sf9 cells for expression of RPA. Typically, the three baculoviruses containing a His-tagged RPA70, RPA34, or RPA12 were used to infect 1 liter of Sf9 cells (2 x 106 cells/ml) with a MOI of 5 (ratio of viruses, 2:2:3). The cells were harvested by centrifugation at 500 x g 40 h postinfection. The RPA was then purified with a Ni-NTA agarose column equilibrated with buffer 1 (25 mM HEPES-KOH, pH 7.7, 1.5 mM MgCl2, 5 mM imidazole, 10% glycerol, and 0.4 M NaCl) and eluted with 100 mM imidazole in buffer 1. RPA-containing fractions were then pooled and loaded onto a Mono Q column equilibrated with buffer 1 and eluted with a 50 to 500 mM NaCl gradient. PCNA was purified from a bacterial expression clone, as described by Fien and Stillman (13). RFC was purified as described by Tsurimoto and Stillman (41) (Fig. 2). Highly purified RFC (the ssDNA chromatography fraction) was used in some assays to confirm the requirement for RFC but, typically, RFC purified from the second P-Cell chromatography was used in replication assays, as this fraction is stably stored. Ad DBP was purified from Ad-infected-293 cell extracts as described by Brush et al. (4).

DNA polymerase purification. DNA Pol {alpha} was purified from the P-Cell IIB fraction of an Ad-infected-293 cell extract using immunoaffinity chromatography (SJK237-71 antibody) as described previously (42) except that the antibody was coupled with CNBr-activated Sepharose. The final concentration was 15 µg/ml, with a primase activity of 7.9 nmol/h/µl. Immunodepletion of Pol {alpha} was performed by chromatography of an Ad-infected cell extract on a Pol {alpha} immunoaffinity column (SJK237-71 antibody) as previously described (25). Western blot and primase assays were used to confirm Pol {alpha} depletion.

DNA Pol {varepsilon} was purified from the P-Cell IIA fraction as described by Syvaoja and Linn (39) (specific activity, 348 nmol/h/mg [3H]dTTP incorporated). Pol {varepsilon} did not contain any Pol {alpha} or {delta}, as judged by Western analysis. Pol {delta} was partially purified from P-Cell IIA fraction on a DEAE-Sepharose column as for the Pol {varepsilon} purification. Fractions that showed significant absorbance at 280 nm were examined by Western analysis and tested for polymerase activity using activated DNA. The Pol {delta} fractions did not contain either Pol {alpha} or Pol {varepsilon}, as seen by Western analysis. Baculovirus expression clones of the Pol {delta} subunits were kindly provided by Jesper Christensen (8). Typically, the four baculoviruses individually containing Pol {delta} 125, His-tagged Pol {delta} 66, Pol {delta} 50, and Pol {delta} 12 were used to infect 1 liter of Sf9 cells (2 x 106 cells/ml) with a MOI of 5 (ratio of viruses, 3:2:1:2). The cells were harvested by centrifugation at 500 x g 40 h postinfection. The Pol {delta} complex was purified with P-Cell chromatography as described above for crude 293 cell extracts except that the polymerase was eluted using 0.45 M NaCl (essentially pooling fractions IIA and IIB). This fraction was then purified on a Ni-NTA column as described for RPA.

AAV DNA replication assay. No-end (NE) substrate was prepared as previously described by Snyder et al. (35) (Fig. 1). In some cases, a linear double-stranded DNA (dsDNA) substrate was used. This substrate was generated from a PvuII digest of the plasmid psub201 as described by Samulski et al. (31).

The standard replication reaction was done as previously described by Ni et al. (28, 29), and the reaction mixture contained, in 15 µl, 30 mM HEPES, 7 mM MgCl2, 0.5 mM DTT, 4 mM ATP, 6 µCi [{alpha}-32P]dATP, 100 µM deoxynucleoside triphosphate, 40 mM creatine phosphate, 33 ng creatine phosphokinase, 0.05 µg NE, and 0.1 to 1.0 µg Rep78 and crude extract or purified replication proteins. Reaction mixtures were incubated for 3 h at 37°C, and then reactions were stopped with 35 µl of stop solution (0.3% sodium dodecyl sulfate [SDS], 17 mM EDTA, 0.7 µg/ml proteinase K). The samples were extracted with phenol-chloroform and precipitated with ethanol. The DNA was digested with DpnI for 1 h at 37°C and fractionated on a 0.8% agarose gel. The gels were dried and exposed to X-ray film and/or a Fuji phosphorimager screen. Where indicated in the figure legends, an aliquot of the reaction products was also was spotted onto DE-81 filter paper. The paper was then washed with 0.5 M NaH2PO4 before counting the dAMP incorporation with a scintillation counter.

Polymerase assays. The reaction mixture contained, in 15 µl, 30 mM HEPES, 7 mM MgCl2, 10% glycerol, 0.5 mM DTT, 4 mM ATP, 30 ng poly(dA)/oligo(dT) (Pharmacia; A-T ratio, 1:1), 0.75 µCi [3H]dTTP, and 1 to 20 µg of polymerase. Reaction mixtures were incubated at 37°C for 30 min before the reaction was stopped by chilling on ice. An aliquot (5 to 8 µl) was spotted onto DE-81 paper, washed, and quantified in a scintillation counter. In some cases activated salmon sperm DNA (Pharmacia, 50 ng DNA per reaction) was used as a substrate in place of the poly(dA)/oligo(dT). Pol {alpha} primase assays were performed as previously described by Chui and Linn (9). One unit of polymerase activity equals 1 nmol [3H]dTTP/h.


arrow
RESULTS
 
P-Cell chromatography of Ad-infected-cell extracts. To identify viral and cellular replication factors that play a role in AAV DNA replication, we fractionated Ad-infected-cell extracts using a purification scheme similar to that used to study simian virus 40 (SV40) DNA replication (Fig. 2). Ad-infected-cell extracts were used because they consistently achieved 10- to 20-fold-higher synthesis of full-length DpnI-resistant AAV DNA in the Rep dependent AAV DNA replication assay. This mirrored a better-than-100-fold difference in DNA replication seen in vivo between uninfected and Ad-infected cells. Extracts derived from Ad-infected 293 cells were subjected to P-Cell chromatography to generate fractions I, IIA, IIB, IIC, and IID. In some instances the 0.4 M NaCl elution was not performed and the fraction eluted with 0.66 M NaCl was termed fraction IIC'. IIC', therefore, contained what was usually in IIB and IIC.

The location of known cellular DNA replication factors within each fraction was then determined by Western blot analysis (Fig. 3A). As expected, RPA and PCNA were observed in fraction I and RFC was present within fraction IIC (Fig. 3A). Ad DBP was mostly located in fraction IIB but was also present in IIA and IIC. In addition, we analyzed each P-Cell fraction for DNA polymerase activity using activated salmon sperm DNA as the template. The majority of the DNA polymerase activity, as judged by incorporation of radioactive deoxynucleotides into DNA, was recovered in fraction IIA; little or no activity could be detected in fraction I, IIC, or IID. These results were consistent with the known fractionation patterns of cellular and viral DNA polymerases on P-Cell. A silver-stained SDS-polyacrylamide gel of the P-Cell fractions is shown (see Fig. 5A).


Figure 3
View larger version (52K):
[in this window]
[in a new window]

  		FIG. 3. P-Cell separation of replication proteins from Ad-infected cells. (A) Western blots of fractions I, IIA, IIB, and IIC with Pol {delta}, Pol {varepsilon}, Pol {alpha}, Ad DBP, RFC, RPA, and PCNA antibodies. (B) Reconstitution of AAV DNA replication in vitro using fractionated Ad-infected-cell extracts. Standard replication reaction mixtures (30 µl) contained either crude Ad-infected-cell extract (C; 200 µg) or P-Cell fractions (I, 160 µg; IIA, 36 µg; IIC', 30 µg; IID, 9 µg) and Rep78 (3.4 µg), as indicated. Reaction mixtures were incubated for 2 h at 37°C, processed, and analyzed as described in Materials and Methods. The DNA products from each reaction were digested with DpnI and analyzed on 0.8% Tris-borate-EDTA (TBE)-agarose. md and dd indicate monomer duplex and dimer duplex DNA species, respectively, which are resistant to DpnI digestion. DNA products sensitive to DpnI digestion are denoted by the black line. (C) Optimization of AAV DNA replication with RFC and P-Cell fractions I and IIA. Standard replication reaction mixtures (15 µl) contained either crude Ad-infected-cell extract (C; 100 µg) or P-Cell fraction I (80 µg), RFC (0.5 µg), Rep78 (1.7 µg), and various amounts of fraction IIA (IIA total protein concentration, 6 mg/ml), as indicated. Reaction mixtures were incubated for 2 h at 37°C, processed, and analyzed as described in Materials and Methods. Half of each reaction mixture was subjected to DpnI digestion and analyzed on 0.8% TBE-agarose; the remaining half was used to quantify [32P]dAMP incorporation using a DE-81 filter binding assay (expressed as pmol of dAMP incorporated per 15 µl reaction mixture). The migration pattern and fragment size of radiolabeled HindIII-digested lambda DNA are indicated on the left.


Figure 5
View larger version (70K):
[in this window]
[in a new window]

  		FIG. 5. (A) Silver-stained polyacrylamide gel of fractions used in this study and purified from Ad-infected-cell extracts. Lane C, Ad-infected-cell extract (2 µl, 92 µg); IIA, 5 µl, 55 µg; IIB, 5 µl, 30 µg; IIC, 5 µl, 25 µg; I, 5 µl, 115 µg; IA, 5 µl, 34 µg; IB, 5 µl, 40 µg; IC, 5 µl, 4.7 µg. (B) Silver stain of an SDS-polyacrylamide gel of purified protein fractions: DEAE Pol {delta} from uninfected extract (15 µl, 16.5 µg), Ad BDP (5 µl, 0.65 µg), PCNA (2.5 µl, 0.7 µg), baculovirus-expressed RPA (20 µl, 5 µg), RFC from Ad-infected-cell extract (40 µl, 0.6 µg), Pol {varepsilon} from uninfected extract (40 µl, 3.8 µg), and baculovirus-expressed Pol {delta} (30 µl, 3.2 µg). Arrows indicate the molecular masses of the expected subunits in each complex.

Reconstitution of AAV DNA replication with P-Cell fractions I, IIA, and IIC. Replication reactions were performed with the substrate NE DNA, AAV Rep78 purified from baculovirus-infected SF9 cells, and various combinations of the P-Cell fractions described above. NE DNA contained no free 3'OH ends (both ends are covalently closed in the hairpin configuration) and was shown previously by us to require Rep for initiation of DNA replication from the AAV TR (29, 35). The use of NE DNA helped to insure that the replication was TR (that is, ori) specific. However, similar results were obtained when a linear duplex AAV DNA genome that contained open ends was used as shown by others (45).

To measure the extent of DNA replication, the DNA products from each reaction were resolved on neutral agarose following restriction analysis with DpnI. As seen in Fig. 3B, full-length AAV DpnI-resistant monomer and dimer products were readily detectable in reactions carried out with crude Ad-infected-cell extracts. We also observed radiolabeled DpnI-sensitive DNA from these reactions. The amount of these unmethylated products was variable, and we are not certain what caused them. They may reflect initiation events that do not lead to elongation (Fig. 3B) or interruption of elongation by DNA endonucleases or proteins (e.g., transcription factors) that block elongation.

When crude extracts were replaced with various P-Cell fractions, we discovered that fractions I, IIA, and IIC' were all that was required for recovery of significant levels of AAV DNA replication (Fig. 3B). These findings parallel the known requirements for reconstitution of SV40 DNA replication using similar P-Cell fractions derived from 293 cellular extracts. The absence of Rep78 protein gave no replication with the NE substrate as expected (Fig. 3B, lane 8).

Studies of SV40 DNA replication identified RFC as the essential component in fraction IIC (41). We therefore, replaced fraction IIC with RFC that was purified from uninfected 293 cells. The purified RFC restored the level of DNA replication to that of the crude extract once an appropriate level of polymerase fraction IIA was used (Fig. 3C, compare lanes 1, 8, and 9). This demonstrated that RFC was probably the only component from fraction IIC that was required for DNA replication. In the absence of RFC there was a small amount of monomer duplex product (Fig. 3C, lane 11) which was DpnI resistant. We believe that this was probably due to a small amount of RFC contamination in fraction IIA or possibly incomplete DpnI digestion of the DNA.

P-Cell fraction I. To analyze fraction I further, we used Q-Sepharose chromatography to generate four fractions (IA, IB, IC, and ID; Fig. 2 and 3). Western blot analysis revealed that fraction IB contained RPA and fraction IC contained PCNA (Fig. 4A). There was no Ad DBP, Pol {delta}, or Pol {varepsilon} in fraction I (Fig. 3A) or in the fractions derived from fraction I. Silver-stained SDS-polyacrylamide gel for these fractions (IA, IB, and IC) as well as the P-Cell II fractions is shown in Fig. 5A. In our replication reconstitution analysis, we found that only IA and IC were essential for DNA replication (Fig. 4B, compare lanes 5 and 7 with lanes 3 and 8). When IA and IC were combined with Rep78, RFC, and polymerase fraction IIA, nearly all of the replication activity was restored. Fraction IB, which contained all of the RPA (Fig. 4A), was not required.


Figure 4
View larger version (56K):
[in this window]
[in a new window]

  		FIG. 4. Q-Sepharose chromatography of P-Cell fraction I from Ad-infected cells. (A) Western blot analysis of Q-Sepharose fractions IA, IB, IC, and ID. RPA (lane 1, 0.7 µg), PCNA (lane 2, 1.7 µg), P-Cell fraction I (400 µg), and Q-Sepharose fractions IA (250 µg), IB (188 µg), IC (60 µg), and ID (6.3 µg) were resolved on 10% SDS-polyacrylamide and then transferred to nitrocellulose. The nitrocellulose filter was probed with RPA (70-kDa subunit) and PCNA monoclonal antibodies. (B) Reconstitution of AAV DNA replication with Q-Sepharose fractions. Standard replication reaction mixtures (15 µl) contained P-Cell fractions I (80 µg) and IIA (24 µg); RFC (0.5 µg); Rep78 (1.7 µg); and Q-Sepharose fractions IA (50 µg), IB (38 µg), IC (12 µg), and ID (1.3 µg), as indicated. Reaction mixtures were incubated for 2 h at 37°C and processed as described in Materials and Methods. md and dd indicate monomer duplex and dimer duplex DNA species, respectively. (C) Replacement of Q-Sepharose fraction IC with PCNA. Standard replication reaction mixtures (15 µl) contained P-Cell fraction IIA (24 µg), RFC (0.5 µg), Rep78 (1.7 µg), Q-Sepharose fractions IA (50 µg) and IC (12 µg), RPA (0.7 µg), and PCNA (lanes 6 to 10, 17 ng, 34 ng, 85 ng, 170 ng, and 340 ng, respectively; lanes 11 and 12; 340 ng), as indicated. Reaction mixtures were incubated for 2 h at 37°C and processed as described in Materials and Methods.

Since fraction IC contains PCNA, we performed a substitution experiment where we replaced fraction IC with pure PCNA (Fig. 4C). PCNA successfully restored the activity of the IC fraction. However, fraction IA was still required for full activity (Fig. 4C, compare lanes 3 and 4, and lanes 10 and 11). Examination of fraction IA by Western analysis showed that this fraction was devoid of proteins likely to be involved in leading strand DNA replication (Fig. 3A and 4A). Replacement of IA with purified RPA was unsuccessful at recovering the activity of the IA fraction, so the IA component was not likely to be an ssDNA binding protein (Fig. 4C, lane 12). Thus, PCNA and an unknown factor(s) in fraction IA are essential for reconstituting AAV DNA replication from fraction I.

Fraction IA. Fraction IA contained a small amount of material that reacted with Pol {alpha} antibody (Fig. 3A). In our previous work, high concentrations of Pol {alpha} neutralizing antibody appeared to inhibit AAV replication in vitro. Although there is no role for a primase in the known mechanism for AAV DNA replication, it was conceivable that Pol {alpha} or a protein complexed with a subset of Pol {alpha} might be necessary for AAV DNA replication. We therefore, used a monoclonal antibody to Pol {alpha} to quantitatively immunodeplete Pol {alpha} from an Ad-infected-cell crude extract. The extract that was depleted of Pol {alpha} did not show any decrease in AAV replication (data not shown). Moreover, addition of immunoaffinity-purified and concentrated Pol {alpha} back to the depleted extract did not enhance replication activity. Thus, neither the absence of Pol {alpha} nor the addition of factors that might purify when complexed to Pol {alpha} appeared to affect replication activity. Pol {alpha} was also unable to reconstitute replication when added with other purified replication factors to a replication assay (data not shown). Therefore, we concluded that Pol {alpha} was not the factor in fraction IA that seemed to be required for AAV DNA replication. Using similar techniques, we examined fraction IA for the presence of a variety of other DNA related enzymes. These included the BLM helicase, the WRN helicase, high mobility group proteins 1 and 2 (HMG1 and -2), and Cdk1. None of these proteins, when added back to the reaction by themselves or inhibited with a commercial inhibitor, were able to substitute for fraction IA (data not shown). Rep52 also did not reconstitute the activity of fraction IA (data not shown).

DNA polymerase required for AAV DNA replication. To identify the DNA polymerase(s) necessary for AAV DNA replication, fraction IIA was fractionated further. The DNA polymerase activity of IIA was resolved on Q-Sepharose using a linear gradient, and three DNA polymerase peaks were pooled, IIA1, IIA2, and IIA3 (Fig. 6A). The bulk of the polymerase activity was in fractions IIA2 and IIA3, and these were tested for their dependence on PCNA (Fig. 6B and C). The IIA2 fraction displayed PCNA-dependent polymerase activity, which is consistent with the presence of Pol {delta} (Fig. 6B), and the IIA3 fraction displayed PCNA-independent polymerase activity, which suggests Pol {varepsilon} activity (Fig. 6C). When the Q-Sepharose fractions were used in reconstitution assays, it was clear that only fraction IIA2 had significant DNA replication activity on the AAV template (Fig. 6D). This was confirmed further with a titration of fraction IIA2 which showed increased replication levels with increasing amounts of fraction IIA2 (Fig. 6E). These data suggested that Pol {delta} is the active polymerase for AAV DNA replication.


Figure 6
View larger version (55K):
[in this window]
[in a new window]

  		FIG. 6. Q-Sepharose chromatography of P-Cell fraction IIA from Ad-infected cells. (A) DNA polymerase activity profile of Q-Sepharose fractions. DNA polymerase activity of each fraction was assayed by measuring the incorporation of dAMP into activated DNA. Standard reaction mixtures (25 µl) contained 3 µl of each fraction and were incubated for 30 min at 37°C. Incorporation of dAMP into DNA was quantified using a DE-81 filter binding assay and is expressed as dAMP (pmol) incorporated per 25 µl reaction mixture. IIA1, IIA2, and IIA3 represent pooled fractions used to reconstitute DNA replication. (B) PCNA-dependent and independent DNA polymerase activities of Q-Sepharose fraction IIA-2 as described in Materials and Methods (PCNA, 255 ng). (C) PCNA-dependent and independent DNA polymerase activities of Q-Sepharose fraction IIA-3 as described in Materials and Methods (PCNA, 255 ng). (D) Reconstitution of AAV DNA replication with Q-Sepharose fractions. Standard replication reaction mixtures (15 µl) contained P-Cell fraction I (80 µg); RFC (0.5 µg); Rep78 (1.7 µg); IIA (24 µg); or Q-Sepharose fractions IIA1 (5 µg), IIA2 (10 µg), and IIA3 (7.5 µg), as indicated. md and dd indicate monomer duplex and dimer duplex DNA species, respectively. (E) Titration of Q-Sepharose fraction IIA2. Standard replication reaction mixtures (15 µl) were as described above except that various amounts of IIA2 (lanes 5 to 8, 3 µg, 6 µg, 12 µg, and 18 µg, respectively) were used to substitute for fraction IIA. All reaction mixtures were incubated for 4 h at 37°C and processed as described in Materials and Methods. [32P]dAMP incorporation was measured as described for Fig. 3.

Fraction IIA, as shown in Fig. 3A, contains Ad DBP. In our attempts to further purify Pol {delta} from fraction IIA we were never successful in separating Pol {delta} from Ad DBP. Therefore, to eliminate the possible contribution of Ad DBP, we fractionated uninfected-293 cell extracts. A DEAE-Sepharose fractionation of uninfected-cell IIA proteins yielded two peaks of polymerase activity (Fig. 7A). Western analysis showed that peak 1 is due to Pol {delta} activity and that peak 2 activity is mostly due to Pol {varepsilon} but also contained some Pol {delta} (Fig. 7B). Reconstitution of in vitro DNA replication showed that the Pol {delta} peak fractions (pool of fractions 10 and 11) restored DNA replication (Fig. 7C). The Pol {varepsilon}-containing fraction showed only a small amount of DNA replication activity. To determine if this activity was due to Pol {varepsilon} or the contaminating Pol {delta}, we further purified Pol {varepsilon} (Fig. 2) to remove any traces of Pol {delta} (Fig. 8A) and then examined DNA replication (Fig. 8B, lanes 12 to 18). Unlike purified Pol {delta}, the purified Pol {varepsilon} did not show any AAV DNA replication. Figure 8B also shows that Pol {delta} requires the factors that we had already identified from previous fractions: PCNA, RFC, and IA. A silver-stained polyacrylamide fractionation gel of the purified proteins is shown in Fig. 5B.


Figure 7
View larger version (48K):
[in this window]
[in a new window]

  		FIG. 7. DEAE-Sepharose fractionation of DNA polymerases from P-Cell fraction IIA of uninfected-293 cell extract. (A) DNA polymerase activity of fractions from DEAE Sepharose (see Materials and Methods). (B) Western blot of DEAE fractions using anti-Pol {delta} and anti-Pol {varepsilon} antibodies which were probed for sequentially without stripping the blot between antibodies. (C) In vitro AAV DNA replication. Standard replication reaction mixtures (15 µl) contained, as shown, the following components: crude extract (60 µg), RFC (0.01 µg), Rep78 (0.2 µg), PCNA (0.4 µg), IA (6 µg), DEAE-Sepharose fractions 10 and 11 of the Pol {delta} pool (0.44 mg/ml), and fractions 13 to 15 of the Pol {varepsilon} pool (2.6 mg/ml), as indicated. md and dd indicate monomer duplex and dimer duplex DNA species, respectively, which are resistant to DpnI digestion.


Figure 8
View larger version (37K):
[in this window]
[in a new window]

  		FIG. 8. Comparison of DNA Pol {delta} and Pol {varepsilon}. (A) Western blot using anti-Pol {delta} and anti-Pol {varepsilon} (blot probed sequentially with antibodies) shows that fractions of the DEAE fraction of Pol {delta} (shown in Fig. 7) did not contain Pol {varepsilon} and that the Mono S fraction of Pol {varepsilon} did not contain Pol {delta}. (B) In vitro AAV DNA replication with various purified DNA replication components. Standard replication reaction mixtures (15 µl) contained crude extract (60 µg), RFC (0.01 µg), Rep78 (0.2 µg), PCNA (0.4 µg), IA (6 µg), DEAE Pol {delta} (2 µg, 16 nmol [3H]dTTP/h/µl), and Mono S Pol {varepsilon} (0.4 µg, 348 nmol [3H]dTTP/h/µl), as indicated. md and dd indicate monomer duplex and dimer duplex DNA species, respectively.

To confirm that Pol {delta} is indeed the polymerase required for replication, Pol {delta} purified from uninfected 293 cell extracts was replaced with Pol {delta} purified from baculovirus-infected SF9 cells. The baculovirus-expressed Pol {delta} was capable of substituting for the activity of the 293 cell extract Pol {delta} (Fig. 9), and the amounts of AAV replication with Pol {delta} from the 293 cell extract (0.38 pmol [3H]dTTP/U of enzyme) and the baculovirus-expressed Pol {delta} (0.39 pmol 3H-dTTP/U of enzyme) were equivalent. These findings are consistent with Pol {delta}, and not Pol {alpha} or {varepsilon}, as the AAV replicative polymerase.


Figure 9
View larger version (57K):
[in this window]
[in a new window]

  		FIG. 9. Replacement of Pol {delta} purified from 293 cell extracts with baculovirus-expressed Pol {delta} in the in vitro DNA replication assay. Standard replication reaction mixtures (15 µl) contained crude RFC (0.01 µg), Rep78 (0.2 µg), PCNA (0.4 µg), IA (6 µg), DEAE Pol {delta} (0.43 mg/ml, 7 nmol [3H]dTTP/h/µl), baculovirus-expressed Pol {delta} (0.024 mg/ml, 1.7 nmol [3H]dTTP/h/µl), RPA (30 to 260 ng), and Ad DBP (15 to 130 ng), as indicated. The amount of 32P incorporation for the monomer AAV replication species was determined by phosphorimager analysis and is indicated for each lane. md and dd indicate monomer duplex and dimer duplex DNA species, respectively.

ssDNA binding proteins. Since we avoided using Ad DBP by using a Pol {delta} preparation from uninfected-cell extracts and since the only partially purified fraction that remained (fraction IA) was negative for both RPA and Ad DBP, our reconstituted assay did not contain ssDNA binding protein. Because several groups have suggested that ssDNA binding proteins were necessary for AAV DNA replication (28, 37, 46), we examined the effect of adding back either purified RPA or purified Ad DBP. Addition of purified RPA was found to enhance replication ~1.5-fold (Fig. 9). Similarly, Ad DBP stimulated replication to the same extent as RPA (Fig. 9). However, in all experiments with Ad DBP, we saw inhibition of DNA replication at the highest DBP concentration (Fig. 9, lane 12). As we could not detect other proteins in our purified Ad DBP preparations, we do not believe this was due to a contaminating inhibitor in the purified Ad DBP. We also tested if the addition of either Ad DBP or RPA to Pol {varepsilon} could reconstitute replication, and it did not (data not shown). Therefore, we concluded that DNA binding proteins appeared to increase DNA replication in vitro approximately 50%, but were not essential for activity.

The DNA helicase requirement. During AAV DNA replication, there are three steps that could require a DNA helicase activity. The first is the terminal resolution step, in which Rep creates a single-stranded bubble at the terminal resolution site and cleaves it (3). Following this event, Rep is also capable of unwinding the TR sequence so that DNA polymerase can fill in the TR to synthesize a complete duplex molecule (35). The second step involves unwinding the duplex TR to form a hairpin that initiates strand displacement synthesis in a process we have called reinitiation (Fig. 1). Finally, a helicase (or DNA binding protein) is necessary to unwind the duplex molecule during strand displacement synthesis. These last two steps are coupled; if the TR is not denatured and reannealed to form a hairpin primer, strand displacement cannot proceed. We have shown previously that Rep protein can bind to a linear TR and unwind it (53).

To determine if Rep68 is able to unwind double-stranded linear AAV DNA and allow strand displacement synthesis to take place, we incubated Rep68 with PuvII-ClaI-digested psub201 DNA. PuvII-ClaI-psub201 DNA digests contain a linear AAV genome, which is missing only 13 bases from either end, and two cloning vector fragments (Fig. 1). The two vector fragments were purposely not separated from the AAV DNA to serve as internal controls because they, unlike the AAV DNA, do not have TR sequences and thus should be incapable of undergoing self-primed replication. As a result, the two vector fragments would be sensitive to DpnI digestion, whereas any replicated AAV DNA would become resistant to the treatment. The missing 13 bases of AAV sequence have been shown previously not to affect Rep binding or DNA replication activity, and they are replaced immediately after the hairpin primer is extended (31). We have shown previously that Rep68 and Rep78 have similar biochemical activities and are essentially indistinguishable in the in vitro DNA replication assay (28).

As shown in Fig. 10A, neither Ad-infected- nor uninfected-cell extracts were capable of stimulating strand displacement synthesis on linear AAV DNA in the absence of Rep protein. However, when Rep68 was added to the reactions, AAV DNA replication took place, suggesting that Rep68, but not cellular helicases, was required to unwind the TR to form the hairpin primer and possibly unwind the remainder of the DNA ahead of the replication fork.


Figure 10
View larger version (53K):
[in this window]
[in a new window]

  		FIG. 10. Examining the helicase activity of Rep in AAV DNA replication using linear dsDNA substrate (0.1 µg of PvuII-digested psub201). (A) Standard replication assay with either Ad-infected-cell or uninfected-cell crude extract (487 µg) and Rep68 (67 µg), as indicated. (B) Standard replication assay with T4 DNA polymerase (1.5 U; New England Biolabs), gene 32 protein (gp32) (1 µg; Pharmacia), and Rep68 (13 µg), as indicated. md indicates the monomer duplex DNA species.

To determine if Rep alone was capable of unwinding the genome during strand displacement synthesis, we designed an artificial replication system that contained only purified Rep68, T4 DNA polymerase, and the T4 DNA binding protein, gene 32 protein (gp32). As shown in Fig. 10B, the addition of Rep68 to the reaction enabled strand displacement synthesis of AAV DNA by T4 DNA polymerase to proceed efficiently. Omission of gp32 showed that Rep68 and T4 DNA polymerase alone were sufficient to generate significant amounts of fully replicated AAV DNA (Fig. 10C). The level of monomer duplex DNA synthesized with T4 polymerase and gene 32 protein was approximately 30% of that seen with Ad-infected-cell crude extracts. Finally, no incorporation of labeled nucleotides was seen in the two vector fragments that were also present as templates in the reaction mixture. This demonstrated that the replication reaction was specific for DNA containing an AAV TR.


arrow
DISCUSSION
 
The replicative polymerase. Pol {delta} was an obvious candidate for the replicative polymerase required for AAV DNA replication. Studies of SV40 DNA replication in vitro had shown that Pol {delta} was the leading strand DNA polymerase, and AAV DNA replicates exclusively by a leading strand mechanism. The requirement for PCNA and RFC is also consistent with Pol {delta} as the replicative polymerase. PCNA was originally identified as a Pol {delta} processivity factor, and RFC assembles PCNA onto 3'OH primers. Our evidence that these two factors were necessary for in vitro AAV DNA replication in Ad-infected-cell extracts confirms our earlier work with uninfected extracts.

Nevertheless, SV40 DNA can be replicated in vitro with Pol {alpha} alone (50), and PCNA has also been shown to be an accessory protein for Pol {varepsilon} (33). Furthermore, in our previous work with uninfected extracts we could not substitute purified Pol {delta}, Pol {alpha}, Pol {varepsilon}, or any combination of these for the polymerase fraction (28). Therefore, it was important to identify which polymerase fractionated with AAV DNA replication activity, and that proved to be Pol {delta}. Not only did Pol {delta} emerge as the only polymerase that fractionated with AAV replication activity, but it also functioned when it was purified from heterologous sources and added back as a purified protein.

Finally, it was important as well to eliminate the possible contribution of Pol {alpha} to AAV DNA replication. Pol {alpha} was the first DNA polymerase that was shown to be capable of replicating a parvovirus genome in vitro (24), and it has been suggested that the autonomous parvovirus minute virus of mice (MVM) may have an internal bidirectional origin for DNA replication that may function in addition to its terminal sequences (11, 12).

The identification of Pol {delta} as the replicative AAV polymerase is consistent with two other observations. Christensen and Tattersall (8) found that purified Pol {delta}, RPA, PCNA, and RFC were the minimum cellular factors required for rolling-circle replication from a 3'-dimer junction of MVM when added back to an in vitro reaction mixture that also contained the MVM NS1 protein and the cellular PIF protein. MVM dimer junctions are believed to be one of the key replicative intermediates that lead to the synthesis of progeny DNA. In addition, Jurvansuu et al. (22) also implicated Pol {delta} in an AAV-induced repair reaction. In these experiments UV-treated AAV infection arrested cells at G2/M. When infected cells were processed for chromatin immunoprecipitation, AAV DNA was found to be associated with RPA and Pol {delta} but not Pol {alpha} or {varepsilon}.

The identification of Pol {delta} as the replicative polymerase would also explain why AAV is capable of replication in cells from a variety of species ranging from insects to humans. Pol {delta}, PCNA, and RFC are highly conserved enzymes, and interaction of Rep with these cellular replicative enzymes would explain AAV's species promiscuity both during productive infections and during transduction with AAV vectors when a limited second strand synthesis is believed to occur.

No role for ssDNA binding protein. As we purified the components of the AAV DNA replication reaction, it became clear that ssDNA binding protein (neither RPA nor Ad DBP) was not required for replication. In contrast, experiments with crude extracts showed some role for ssDNA binding proteins (28, 46). We can imagine several possible explanations. First, ssDNA binding proteins may be required in vivo and in crude extracts to protect single-stranded template DNA or the single-stranded progeny DNA from random nicking during strand displacement synthesis or from binding by other proteins that might interfere with DNA replication. This is believed to be the primary role for ssDNA binding proteins in vivo (for a review see reference 10). Once the replication enzymes are purified, RPA, Ad DBP, and the herpesvirus UL29 protein may no longer be essential. We note, for example, that, in spite of the apparent tight requirement for UL29 in herpesvirus-infected cells and in crude extract experiments in vitro (37, 48), only a twofold reduction in DNA synthesis was seen when UL29 was omitted from in vitro reaction mixtures that contained only purified herpesvirus replication proteins (47). It is also worth noting that RPA interacts with a wide variety of cellular DNA replication and repair enzymes in addition to the Rep protein (10). It is believed that these interactions are used in part to displace RPA from DNA so that the polymerase complex can use exposed ssDNA as a template (10). Since AAV clearly uses cellular enzymes for DNA replication, this may explain why Ad DBP and not RPA inhibits AAV DNA replication at high concentrations. Ad DBP may not have the correct set of interactions with the replicative complex during strand displacement that are required to remove Ad DBP ahead of the polymerase complex.

Second, it is possible that an excess of Rep78 or Rep68, which are both ssDNA binding proteins and DNA helicases, may be sufficient to both protect and unwind the template, thereby substituting for ssDNA binding protein. This might also explain the puzzling fact that herpesvirus helicase primase (UL5, -8, and -52) did not affect in vitro replication when it was omitted from a reaction mixture that contained Rep, the herpesvirus polymerase complex, and the herpesvirus ssDNA binding protein (47).

Third, it may be that the intracellular role of ssDNA binding proteins is to help colocalize Rep and cellular replication enzymes onto ssDNA in replication foci within the nucleus. This has been suggested by several groups and would account for the ssDNA-stimulated interaction of Rep and RPA, Rep and DBP (37), and Rep and UL29 (15). However, it leaves the puzzling question of why there is clear evidence of a genetic requirement for AAV DNA replication only in the case of UL29 (15, 37, 48).

The missing factor(s) in P-Cell IA. We could not identify the factor(s) in fraction IA that was responsible for stimulation of AAV DNA replication to the levels seen in Ad-infected-cell crude extracts. Attempts to purify the factor failed, suggesting either that the factor was unstable or consisted of a complex that fractionated into multiple parts upon further fractionation. This factor is of considerable interest since it remains a puzzle as to what factor is induced by the Ad helper that stimulates AAV DNA synthesis in vitro by more than 10-fold and in vivo by over a 100-fold.

One potential activity contained within fraction IA could be a DNA helicase. The fact that we were able to replicate AAV DNA in vitro with just three purified enzymes (T4 DNA polymerase, gp32, and Rep) suggests that Rep protein alone could supply the necessary DNA helicase activity for strand displacement synthesis. Ward et al. (47) showed a similar phenomenon when they were able to replicate AAV DNA in vitro with only herpesvirus DNA polymerase, UL29, and Rep protein. However, Rep helicase activity was not sufficient to produce detectable replication in the context of a reaction mixture containing Pol {delta}, PCNA, and RFC (and RPA or Ad DBP). Thus, one or more cellular helicase activities may be the missing factor in fraction IA.


arrow
ACKNOWLEDGMENTS
 
This work was supported by program project grants (to N.M.) from the National Institutes of Health (PO1 HL59412, PO1 HL51811). We also acknowledge support for N.M. from the Edward R. Koger Chair for Basic Cancer Research.

N.M. is inventor on patents related to recombinant AAV technology and owns equity in a gene therapy company that is commercializing AAV for gene therapy applications.

We thank Zengi Li for helpful discussions during the course of this work.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Molecular Genetics and Microbiology, University of Florida, 1376 Mowry Rd., Gainesville, FL 32610. Phone: (352) 273-8114. Fax: (352) 273-8284. E-mail: muzyczka{at}mgm.ufl.edu Back

{triangledown} Published ahead of print on 14 March 2007. Back


arrow
REFERENCES
 
    1
  1. Blacklow, N. R., M. D. Hoggan, A. Z. Kapikian, J. B. Austin, and W. P. Rowe. 1968. Epidemiology of adenovirus-associated virus infection in a nursery population. Am. J. Epidemiol. 88:368-378.[Abstract/Free Full Text]
    2. 2
  2. Blacklow, N. R., M. D. Hoggan, and W. P. Rowe. 1968. Serologic evidence for human infection with adenovirus-associated viruses. J. Natl. Cancer Inst. 40:319-327.[Medline]
    3. 3
  3. Brister, J. R., and N. Muzyczka. 1999. Rep-mediated nicking of the adeno-associated virus origin requires two biochemical activities, DNA helicase activity and transesterification. J. Virol. 73:9325-9336.[Abstract/Free Full Text]
    4. 4
  4. Brush, G. S., T. J. Kelly, and B. Stillman. 1995. Identification of eukaryotic DNA replication proteins using simian virus 40 in vitro replication system. Methods Enzymol. 262:522-548.[Medline]
    5. 5
  5. Buller, R. M., J. E. Janik, E. D. Sebring, and J. A. Rose. 1981. Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication. J. Virol. 40:241-247.[Abstract/Free Full Text]
    6. 6
  6. Carter, B. J., B. A. Antoni, and D. F. Klessig. 1992. Adenovirus containing a deletion of the early region 2A gene allows growth of adeno-associated virus with decreased efficiency. Virology 191:473-476.[CrossRef][Medline]
    7. 7
  7. Chang, L. S., and T. Shenk. 1990. The adenovirus DNA-binding protein stimulates the rate of transcription directed by adenovirus and adeno-associated virus promoters. J. Virol. 64:2103-2109.[Abstract/Free Full Text]
    8. 8
  8. Christensen, J., and P. Tattersall. 2002. Parvovirus initiator protein NS1 and RPA coordinate replication fork progression in a reconstituted DNA replication system. J. Virol. 76:6518-6531.[Abstract/Free Full Text]
    9. 9
  9. Chui, G., and S. Linn. 1995. Further characterization of HeLa DNA polymerase epsilon. J. Biol. Chem. 270:7799-7808.[Abstract/Free Full Text]
    10. 10
  10. Fanning, E., V. Klimovich, and A. R. Nager. 2006. A dynamic model for replication protein A (RPA) function in DNA processing pathways. Nucleic Acids Res. 34:4126-4137.[Abstract/Free Full Text]
    11. 11
  11. Faust, E. A., R. Nagy, and S. K. Davey. 1985. Mouse DNA polymerase alpha-primase terminates and reinitiates DNA synthesis 2-14 nucleotides upstream of C2A1-2(C2-3/T2) sequences on a minute virus of mice DNA template. Proc. Natl. Acad. Sci. USA 82:4023-4027.[Abstract/Free Full Text]
    12. 12
  12. Faust, E. A., and C. D. Rankin. 1982. In vitro conversion of MVM parvovirus single-stranded DNA to the replicative form by DNA polymerase alpha from Ehrlich ascites tumour cells. Nucleic Acids Res. 10:4181-4201.[Abstract/Free Full Text]
    13. 13
  13. Fien, K., and B. Stillman. 1992. Identification of replication factor C from Saccharomyces cerevisiae: a component of the leading-strand DNA replication complex. Mol. Cell. Biol. 12:155-163.[Abstract/Free Full Text]
    14. 14
  14. Fraefel, C., A. G. Bittermann, H. Bueler, I. Heid, T. Bachi, and M. Ackermann. 2004. Spatial and temporal organization of adeno-associated virus DNA replication in live cells. J. Virol. 78:389-398.[Abstract/Free Full Text]
    15. 15
  15. Heilbronn, R., M. Engstler, S. Weger, A. Krahn, C. Schetter, and M. Boshart. 2003. ssDNA-dependent colocalization of adeno-associated virus Rep and herpes simplex virus ICP8 in nuclear replication domains. Nucleic Acids Res. 31:6206-6213.[Abstract/Free Full Text]
    16. 16
  16. Hunter, L. A., and R. J. Samulski. 1992. Colocalization of adeno-associated virus Rep and capsid proteins in the nuclei of infected cells. J. Virol. 66:317-324.[Abstract/Free Full Text]
    17. 17
  17. Im, D. S., and N. Muzyczka. 1990. The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity. Cell 61:447-457.[CrossRef][Medline]
    18. 18
  18. Im, D. S., and N. Muzyczka. 1989. Factors that bind to adeno-associated virus terminal repeats. J. Virol. 63:3095-3104.[Abstract/Free Full Text]
    19. 19
  19. Im, D. S., and N. Muzyczka. 1992. Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization. J. Virol. 66:1119-1128.[Abstract/Free Full Text]
    20. 20
  20. Janik, J. E., M. M. Huston, K. Cho, and J. A. Rose. 1989. Efficient synthesis of adeno-associated virus structural proteins requires both adenovirus DNA binding protein and VA I RNA. Virology 168:320-329.[CrossRef][Medline]
    21. 21
  21. Janik, J. E., M. M. Huston, and J. A. Rose. 1981. Locations of adenovirus genes required for the replication of adenovirus-associated virus. Proc. Natl. Acad. Sci. USA 78:1925-1929.[Abstract/Free Full Text]
    22. 22
  22. Jurvansuu, J., K. Raj, A. Stasiak, and P. Beard. 2005. Viral transport of DNA damage that mimics a stalled replication fork. J. Virol. 79:569-580.[Abstract/Free Full Text]
    23. 23
  23. Kohlbrenner, E., G. Aslanidi, K. Nash, S. Shklyaev, M. Campbell-Thompson, B. J. Byrne, R. O. Snyder, N. Muzyczka, K. H. Warrington, Jr., and S. Zolotukhin. 2005. Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system. Mol. Ther. 12:1217-1225.[Medline]
    24. 24
  24. Kollek, R., B. Y. Tseng, and M. Goulian. 1982. DNA polymerase requirements for parvovirus H-1 DNA replication in vitro. J. Virol. 41:982-989.[Abstract/Free Full Text]
    25. 25
  25. Murakami, Y., C. R. Wobbe, L. Weissbach, F. B. Dean, and J. Hurwitz. 1986. Role of DNA polymerase alpha and DNA primase in simian virus 40 DNA replication in vitro. Proc. Natl. Acad. Sci. USA 83:2869-2873.[Abstract/Free Full Text]
    26. 26
  26. Muzyczka, N., and K. I. Berns. 2001. Parvoviridae: the viruses and their replication, p. 2327-2360. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams and Wilkins, New York, NY.
    27. 27
  27. Myers, M. W., C. A. Laughlin, F. T. Jay, and B. J. Carter. 1980. Adenovirus helper function for growth of adeno-associated virus: effect of temperature-sensitive mutations in adenovirus early gene region 2. J. Virol. 35:65-75.[Abstract/Free Full Text]
    28. 28
  28. Ni, T. H., W. F. McDonald, I. Zolotukhin, T. Melendy, S. Waga, B. Stillman, and N. Muzyczka. 1998. Cellular proteins required for adeno-associated virus DNA replication in the absence of adenovirus coinfection. J. Virol. 72:2777-2787.[Abstract/Free Full Text]
    29. 29
  29. Ni, T. H., X. Zhou, D. M. McCarty, I. Zolotukhin, and N. Muzyczka. 1994. In vitro replication of adeno-associated virus DNA. J. Virol. 68:1128-1138.[Abstract/Free Full Text]
    30. 30
  30. Prelich, G., C. K. Tan, M. Kostura, M. B. Mathews, A. G. So, K. M. Downey, and B. Stillman. 1987. Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 326:517-520.[CrossRef][Medline]
    31. 31
  31. Samulski, R. J., L. S. Chang, and T. Shenk. 1987. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol. 61:3096-3101.[Abstract/Free Full Text]
    32. 32
  32. Schmidt, M., E. Grot, P. Cervenka, S. Wainer, C. Buck, and J. A. Chiorini. 2006. Identification and characterization of novel adeno-associated virus isolates in ATCC virus stocks. J. Virol. 80:5082-5085.[Abstract/Free Full Text]
    33. 33
  33. Shivji, M. K., V. N. Podust, U. Hubscher, and R. D. Wood. 1995. Nucleotide excision repair DNA synthesis by DNA polymerase epsilon in the presence of PCNA, RFC, and RPA. Biochemistry 34:5011-5017.[CrossRef][Medline]
    34. 34
  34. Slanina, H., S. Weger, N. D. Stow, A. Kuhrs, and R. Heilbronn. 2006. Role of the herpes simplex virus helicase-primase complex during adeno-associated virus DNA replication. J. Virol. 80:5241-5250.[Abstract/Free Full Text]
    35. 35
  35. Snyder, R. O., R. J. Samulski, and N. Muzyczka. 1990. In vitro resolution of covalently joined AAV chromosome ends. Cell 60:105-113.[CrossRef][Medline]
    36. 36
  36. Song, S., M. Morgan, T. Ellis, A. Poirier, K. Chesnut, J. Wang, M. Brantly, N. Muzyczka, B. J. Byrne, M. Atkinson, and T. R. Flotte. 1998. Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA 95:14384-14388.[Abstract/Free Full Text]
    37. 37
  37. Stracker, T. H., G. D. Cassell, P. Ward, Y. M. Loo, B. van Breukelen, S. D. Carrington-Lawrence, R. K. Hamatake, P. C. van der Vliet, S. K. Weller, T. Melendy, and M. D. Weitzman. 2004. The Rep protein of adeno-associated virus type 2 interacts with single-stranded DNA-binding proteins that enhance viral replication. J. Virol. 78:441-453.[Abstract/Free Full Text]
    38. 38
  38. Straus, S. E., H. S. Ginsberg, and J. A. Rose. 1976. DNA-minus temperature-sensitive mutants of adenovirus type 5 help adenovirus-associated virus replication. J. Virol. 17:140-148.
    39. 39
  39. Syvaoja, J., and S. Linn. 1989. Characterization of a large form of DNA polymerase delta from HeLa cells that is insensitive to proliferating cell nuclear antigen. J. Biol. Chem. 264:2489-2497.[Abstract/Free Full Text]
    40. 40
  40. Tsurimoto, T., and B. Stillman. 1989. Multiple replication factors augment DNA synthesis by the two eukaryotic DNA polymerases, alpha and delta. EMBO J. 8:3883-3889.[Medline]
    41. 41
  41. Tsurimoto, T., and B. Stillman. 1989. Purification of a cellular replication factor, RF-C, that is required for coordinated synthesis of leading and lagging strands during simian virus 40 DNA replication in vitro. Mol. Cell. Biol. 9:3839-3849.[Abstract/Free Full Text]
    42. 42
  42. Tsurimoto, T., and B. Stillman. 1991. Replication factors required for SV40 DNA replication in vitro. II. Switching of DNA polymerase alpha and delta during initiation of leading and lagging strand synthesis. J. Biol. Chem. 266:1961-1968.[Abstract/Free Full Text]
    43. 43
  43. Urabe, M., C. Ding, and R. M. Kotin. 2002. Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum. Gene Ther. 13:1935-1943.[CrossRef][Medline]
    44. 44
  44. Urabe, M., T. Nakakura, K. Q. Xin, Y. Obara, H. Mizukami, A. Kume, R. M. Kotin, and K. Ozawa. 2006. Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells. J. Virol. 80:1874-1885.[Abstract/Free Full Text]
    45. 45
  45. Ward, P., and K. I. Berns. 1996. In vitro replication of adeno-associated virus DNA: enhancement by extracts from adenovirus-infected HeLa cells. J. Virol. 70:4495-4501.[Abstract]
    46. 46
  46. Ward, P., F. B. Dean, M. E. O'Donnell, and K. I. Berns. 1998. Role of the adenovirus DNA-binding protein in in vitro adeno-associated virus DNA replication. J. Virol. 72:420-427.[Abstract/Free Full Text]
    47. 47
  47. Ward, P., M. Falkenberg, P. Elias, M. Weitzman, and R. M. Linden. 2001. Rep-dependent initiation of adeno-associated virus type 2 DNA replication by a herpes simplex virus type 1 replication complex in a reconstituted system. J. Virol. 75:10250-10258.[Abstract/Free Full Text]
    48. 48
  48. Weindler, F. W., and R. Heilbronn. 1991. A subset of herpes simplex virus replication genes provides helper functions for productive adeno-associated virus replication. J. Virol. 65:2476-2483.[Abstract/Free Full Text]
    49. 49
  49. Weitzman, M. D., K. J. Fisher, and J. M. Wilson. 1996. Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers. J. Virol. 70:1845-1854.[Abstract]
    50. 50
  50. Wobbe, C. R., L. Weissbach, J. A. Borowiec, F. B. Dean, Y. Murakami, P. Bullock, and J. Hurwitz. 1987. Replication of simian virus 40 origin-containing DNA in vitro with purified proteins. Proc. Natl. Acad. Sci. USA 84:1834-1838.[Abstract/Free Full Text]
    51. 51
  51. Yakobson, B., T. A. Hrynko, M. J. Peak, and E. Winocour. 1989. Replication of adeno-associated virus in cells irradiated with UV light at 254 nm. J. Virol. 63:1023-1030.[Abstract/Free Full Text]
    52. 52
  52. Yakobson, B., T. Koch, and E. Winocour. 1987. Replication of adeno-associated virus in synchronized cells without the addition of a helper virus. J. Virol. 61:972-981.[Abstract/Free Full Text]
    53. 53
  53. Zhou, X., I. Zolotukhin, D. S. Im, and N. Muzyczka. 1999. Biochemical characterization of adeno-associated virus rep68 DNA helicase and ATPase activities. J. Virol. 73:1580-1590.[Abstract/Free Full Text]

Journal of Virology, June 2007, p. 5777-5787, Vol. 81, No. 11
0022-538X/07/$08.00+0     doi:10.1128/JVI.02651-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Guan, W., Wong, S., Zhi, N., Qiu, J. (2009). The Genome of Human Parvovirus B19 Can Replicate in Nonpermissive Cells with the Help of Adenovirus Genes and Produces Infectious Virus. J. Virol. 83: 9541-9553 [Abstract] [Full Text]  
  • Schwartz, R. A., Carson, C. T., Schuberth, C., Weitzman, M. D. (2009). Adeno-Associated Virus Replication Induces a DNA Damage Response Coordinated by DNA-Dependent Protein Kinase. J. Virol. 83: 6269-6278 [Abstract] [Full Text]  
  • Nash, K., Chen, W., Salganik, M., Muzyczka, N. (2009). Identification of Cellular Proteins That Interact with the Adeno-Associated Virus Rep Protein. J. Virol. 83: 454-469 [Abstract] [Full Text]  
  • Nash, K., Chen, W., Muzyczka, N. (2008). Complete In Vitro Reconstitution of Adeno-Associated Virus DNA Replication Requires the Minichromosome Maintenance Complex Proteins. J. Virol. 82: 1458-1464 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nash, K.
Right arrow Articles by Muzyczka, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nash, K.
Right arrow Articles by Muzyczka, N.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»